| RAD21 |
RAD21, HR21, KIAA0078, NXP1: Double-strand-break repair protein rad21 homolog |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
1.235 |
Evidence |
|
| CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
EZH2 |
EZH2: Enhancer of zeste homolog 2 |
1.235 |
Evidence |
|
| EIF4E |
EIF4E, EIF4EL1, EIF4F: Eukaryotic translation initiation factor 4E |
MAPRE1 |
MAPRE1: Microtubule-associated protein RP/EB family member 1 |
1.235 |
Evidence |
|
| EIF4E |
EIF4E, EIF4EL1, EIF4F: Eukaryotic translation initiation factor 4E |
COPS3 |
COPS3, CSN3: COP9 signalosome complex subunit 3 |
1.235 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
CTBP1 |
CTBP1, CTBP: C-terminal-binding protein 1 |
1.235 |
Evidence |
|
| FSHB |
FSHB: Follitropin subunit beta precursor |
SGK3 |
SGK3, SGK2, SGKL: Serine/threonine-protein kinase Sgk3 |
1.235 |
Evidence |
|
| P2RY10 |
P2RY10: Putative P2Y purinoceptor 10 |
SSTR2 |
SSTR2: Somatostatin receptor type 2 |
1.232 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
SSTR2 |
SSTR2: Somatostatin receptor type 2 |
1.232 |
Evidence |
|
| SSTR2 |
SSTR2: Somatostatin receptor type 2 |
EDG8 |
EDG8: Sphingosine 1-phosphate receptor Edg-8 |
1.232 |
Evidence |
|
| JAG1 |
JAG1, JAGL1: Jagged-1 precursor |
IL10RB |
IL10RB, CRFB4, D21S58, D21S66: Interleukin-10 receptor beta chain precursor |
1.232 |
Evidence |
|
| P2RY10 |
P2RY10: Putative P2Y purinoceptor 10 |
CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
1.232 |
Evidence |
|
| TUBB |
TUBB, TUBB5, OK/SW-cl.56: Tubulin beta chain |
H2-ALPHA |
TUBA3C, TUBA2, TUBA3D: Tubulin alpha-3C/D chain |
1.232 |
Evidence |
|
| RXRB |
RXRB, NR2B2: Retinoic acid receptor RXR-beta |
NR1H2 |
NR1H2, LXRB, NER, UNR: Oxysterols receptor LXR-beta |
1.232 |
Evidence |
|
| ATP2A1 |
ATP2A1: Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 |
CAMK2D |
CAMK2D, CAMKD: Calcium/calmodulin-dependent protein kinase type II delta chain |
1.232 |
Evidence |
|
| RABGGTB |
RABGGTB, GGTB: Geranylgeranyl transferase type-2 subunit beta |
ARF1 |
ARF1: ADP-ribosylation factor 1 |
1.232 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
GNB2 |
GNB2: Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 |
1.23 |
Evidence |
|
| TOM1L1 |
TOM1L1, SRCASM: TOM1-like protein 1 |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
1.23 |
Evidence |
|
| IFNA14 |
IFNA14: Interferon alpha-14 precursor |
GRK5 |
GRK5, GPRK5: G protein-coupled receptor kinase 5 |
1.23 |
Evidence |
|
| SKI |
SKI: Ski oncogene |
HIPK2 |
HIPK2: Homeodomain-interacting protein kinase 2 |
1.23 |
Evidence |
|
| PROZ |
PROZ: Vitamin K-dependent protein Z precursor |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
1.227 |
Evidence |
|
| EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
PHC2 |
IPI00419684 |
1.227 |
Evidence |
|
| IFNAR1 |
IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor |
DUSP2 |
DUSP2, PAC1: Dual specificity protein phosphatase 2 |
1.227 |
Evidence |
|
| TUBA1 |
TUBA4A, TUBA1: Tubulin alpha-4A chain |
TYRO3 |
TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor |
1.227 |
Evidence |
|
| GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
SMPDL3B |
SMPDL3B, ASML3B: Acid sphingomyelinase-like phosphodiesterase 3b precursor |
1.227 |
Evidence |
|
| PPP3CA |
PPP3CA, CALNA, CNA: Serine/threonine-protein phosphatase 2B catalytic subunit al |
PSMD6 |
PSMD6, KIAA0107, PFAAP4: 26S proteasome non-ATPase regulatory subunit 6 |
1.227 |
Evidence |
O
|
- 
-